Skip to main content

Pharmaka mit Wirkung auf den glatten Muskel

  • Chapter
Pharmakologie und Toxikologie

Part of the book series: Springer-Lehrbuch ((SLB))

  • 853 Accesses

Zusammenfassung

Von der Elektrophysiologie, der Rezeptorausstattung und der Wirkung von Pharmaka her lassen sich 2 Gruppen der glatten Muskulatur differenzieren: intestinaler und vaskulärer Typ. Die glatte Muskulatur des Bronchialsystems nimmt eine Mittelstellung ein.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aguilar-Bryan L, Bryan J (1999) Molecular biology of adenosine triphosphate-sensitive potassium channels. Endocr Rev 20:101–135

    Article  PubMed  CAS  Google Scholar 

  • Ahlner J, Andersson RGG, Torfgard K, Axelsson KL (1991) Organic nitrate esters: Clinical use and mechanisms of ac- tions. Pharmacol Rev 43:351–423

    PubMed  CAS  Google Scholar 

  • Anggard E (1994) Nitric oxide: Mediator, murderer, and me- dicine. Lancet 343:1199–1206

    Article  PubMed  CAS  Google Scholar 

  • Ashcroft FM, Gribble FM (2000) New windows on the mecha- nism of action of K(ATP) channel openers. Trends Phar- macol Sci 21:439–445

    Article  CAS  Google Scholar 

  • Beavo JA (1995) Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 75:725–748

    PubMed  CAS  Google Scholar 

  • Beech DJ (1997) Actions of neurotransmitters and other messengers on Ca2+ channels and K+ channels in smooth muscle cells. Pharmacol Ther 73:91–119

    Article  PubMed  CAS  Google Scholar 

  • Berkels R, Klaus W (2000) Kalziumantagonisten näher betrachtet: Eine bekannte Stoffgruppe mit neuartigem Wirkprinzip? Dtsch Med Wochenschr 125:531–533

    Article  PubMed  CAS  Google Scholar 

  • Berridge MJ (1993) Inositol trisphosphate and calcium signalling. Nature 361:315–325

    Article  PubMed  CAS  Google Scholar 

  • Bootman MD, Berridge MJ (1995) The elemental principles of calcium signaling. Cell 83:675–678

    Article  PubMed  CAS  Google Scholar 

  • Bugrim AE (1999) Regulation of Ca2+ release by cAMP-dependent protein kinase. A mechanism for agonist-specific calcium. Cell Calcium 25:219–226

    Article  PubMed  CAS  Google Scholar 

  • Callewaert G (1992) Excitation-contraction coupling in mammalian cardiac cells. Cardiovasc Res 26:923–932

    Article  PubMed  CAS  Google Scholar 

  • Catterall WA (1995) Structure and function of voltage-gated ion channels. Annu Rev Biochem 64:493–531

    Article  PubMed  CAS  Google Scholar 

  • Catterall WA, Striessnig J (1992) Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci 13:256–262

    Article  PubMed  CAS  Google Scholar 

  • Cody RJ (1994) The clinical potential of renin inhibitors and angiotensin antagonists. Drugs 47:586–598

    Article  PubMed  CAS  Google Scholar 

  • Cooke JP, Dzau VJ (1997) Nitric oxide synthase: Role in the genesis of vascular disease. Annu Rev Med 48:489–509

    Article  PubMed  CAS  Google Scholar 

  • De Zeeuw D, Janssen WMT, De Jong PE (1992) Atrial natriuretic factor: Its (patho)physiological significance in humans. Kidney Int 41:1115–1133

    Article  PubMed  Google Scholar 

  • Dolphin AC (1991) Regulation of calcium channel activity by GTP binding proteins and second messengers. Biochim Biophys Acta 1091:68–80

    Article  PubMed  CAS  Google Scholar 

  • Elkayam U (1991) Tolerance to organic nitrates: Evidence, mechanisms, clinical relevance, and strategies for prevention. Ann Intern Med 114:667–677

    Article  PubMed  CAS  Google Scholar 

  • Fasolato C, Innocenti B, Pozzan T (1994) Receptor-activated Ca2+ influx: How many mechanisms for how many channels. Trends Pharmacol Sci 15:77–83

    Article  PubMed  CAS  Google Scholar 

  • Ferro CJ, Webb DJ (1996) The clinical potential of endothelin receptor antagonists in cardiovascular medicine. Drugs 51:12–27

    Article  PubMed  CAS  Google Scholar 

  • Fleckenstein A (1983) History of calcium antagonists. Circ Res 52 [Suppl I]:3–16

    CAS  Google Scholar 

  • Förstermann U (1994) Biochemistry and molecular biology of nitric oxide synthases. Arzneimittelforschung 44: 402–407

    PubMed  Google Scholar 

  • Förstermann U, Boissel JP, Kleinert H (1998) Expressional control of the „constitutive“ isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 12:773–790

    PubMed  Google Scholar 

  • Frey A, Reif A, Zabel U, Schmidt HH (1998) NO: 10 years after. Biospektrum 2:27–32

    Google Scholar 

  • Friebe A, Schultz G, Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 15:6863–6868

    PubMed  CAS  Google Scholar 

  • Fukata Y, Amano M, Kaibuchi K (2001) Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 22:32–39

    Article  PubMed  CAS  Google Scholar 

  • Galen PJM van, Stiles GL, Michaels G, Jacobson KA (1992) Adenosin A1 and A2 receptors: Structure-function relationships. Med Res Rev 12:423–471

    Article  PubMed  Google Scholar 

  • Garbers DL, Koesling D, Schultz G (1994) Guanylyl cyclase receptors. Mol Biol Cell 5:1–5

    PubMed  CAS  Google Scholar 

  • Gerzer R (1985) Das Herz, ein endokrines Organ: Die Entdeckung eines neuen Hormons. Klin Wochenschr 63:529–536

    Article  PubMed  CAS  Google Scholar 

  • Glossmann H, Striessnig J (1990) Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol 114:1 -105

    Article  PubMed  CAS  Google Scholar 

  • Goldmann B, Stoltefuss J (1991) 1,4-dihydropyridines: Effects of chirality and conformation on the calcium antagonist and calcium agonist activities. Angew Chem (Int Ed Engl) 30:1559–1578

    Article  Google Scholar 

  • Goldstein I, Lue TF, Padma-Nathan H. Rosen RC, Steers WD, Wicker PA (1998) Oral sildenafìl in the treatment of erectile dysfunction. N Engl J Med 20:1397–1404

    Article  Google Scholar 

  • Griendling KK, Lassègue B, Alexander RW (1996) Angiotensin receptors and their therapeutic implications. Annu Rev Pharmacol Toxicol 36:281–306

    Article  PubMed  CAS  Google Scholar 

  • Grobecker H (1994) Calciumantagonisten. Med Monatsschr Pharm 17:130–139

    PubMed  CAS  Google Scholar 

  • Harteneck C, Plant TD, Schultz G (2000) From worm to man: Three subfamilies of TRP channels. Trends Neurosci 23:159–166

    Article  PubMed  CAS  Google Scholar 

  • Hellwig B (1994) Kaliumagonisten. Med Monatsschr Pharm 17:164–167

    PubMed  CAS  Google Scholar 

  • Hockerman GH, Peterson BZ, Johnson BD, Catterall WA (1997) Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol 37:361–396

    Article  PubMed  CAS  Google Scholar 

  • Hofmann F, Biel M, Flockerzi V (1994) Molecular basis for Ca2+ channel diversity. Annu Rev Neurosci 17:399–418

    Article  PubMed  CAS  Google Scholar 

  • Hollenberg MD (1994) Tyrosine kinase pathways and the regulation of smooth muscle contractility. Trends Pharmacol Sci 15:108–114

    Article  PubMed  CAS  Google Scholar 

  • Horowitz A, Menice CB, Laporte R, Morgan KG (1996) Mechanisms of smooth muscle contraction. Physiol Rev 76:967–1003

    PubMed  CAS  Google Scholar 

  • Kam PCA, Govendeer G (1994) Nitric oxide: Basic science and clinical applications. Anaesthesia 49:515–521

    Article  PubMed  CAS  Google Scholar 

  • Kamm KE, Stull JT (1985) The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Annu Rev Pharmacol Toxicol 25:593–620

    Article  PubMed  CAS  Google Scholar 

  • Levin ER (1995) Endothelins. N Engl J Med 333:356–363

    Article  PubMed  CAS  Google Scholar 

  • Levin ER, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 5:321–328

    Google Scholar 

  • Masaki T (1995) Possible role of endothelin in endothelial regulation of vascular tone. Annu Rev Pharmacol Toxicol 35:235–255

    Article  PubMed  CAS  Google Scholar 

  • Matsusaka T, Ichikawa I (1997) Biological functions of angiotensin and its receptors. Annu Rev Physiol 59:395–412

    Article  PubMed  CAS  Google Scholar 

  • Means AR, VanBerkum MFA, Bagchi I, Lu KP, Rasmussen CD (1991) Regulatory functions of calmodulin. Pharmacol Ther 50:255–270

    Article  PubMed  CAS  Google Scholar 

  • Mikoshiba K (1997) The InsP3 receptor and intracellular Ca2+ signaling. Curr Opin Neurobiol 7:339–345

    Article  PubMed  CAS  Google Scholar 

  • Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012

    Article  PubMed  CAS  Google Scholar 

  • Nathan C, Xie QW (1994) Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725–13728

    PubMed  CAS  Google Scholar 

  • Orallo F (1996) Regulation of cytosolic calcium levels in vascular smooth muscle. Pharmacol Ther 69:153–171

    Article  PubMed  CAS  Google Scholar 

  • Pfaffendorf M (1992) Atriales natriuretisches Peptid als Angiotensin-II-Antagonist: Eine neues therapeutisches Prinzip? Med Monatsschr Pharm 15:169–177

    PubMed  CAS  Google Scholar 

  • Pfaffendorf M (1996) Das Endothel als sekretorisches Organ. Med Monatsschr Pharm 19:42–53

    PubMed  CAS  Google Scholar 

  • Pietrobon D, Di Virgilio F, Pozzan T (1990) Structural and functional aspects of calcium homeostasis in eukaryotic cells. Eur J Biochem 193:599–622

    Article  PubMed  CAS  Google Scholar 

  • Pinto-Sietsma SJ, Paul M (1998) A role for endothelin in the pathogenesis of hypertension: Fact or fiction? Kidney Int 54 Suppl 67:115–121

    Article  Google Scholar 

  • Po AL, Zhang WY (1998) What lessons can be learnt from withdrawal of mibefradil from the market? Lancet 351:1829–1830

    Article  PubMed  CAS  Google Scholar 

  • Pongs O (1992) Structural basis of voltage-gated K+-channel pharmacology. Trends Pharmacol Sci 13:359–365

    Article  PubMed  CAS  Google Scholar 

  • Quayle JM, Standen NB (1994) K-ATP channels in vascular smooth muscle. Cardiovasc Res 28:797–804

    Article  PubMed  CAS  Google Scholar 

  • Rembold CM (1992) Regulation of contraction and relaxation in arterial smooth muscle. Hypertension 20:129–137

    Article  PubMed  CAS  Google Scholar 

  • Reynen K (1993) Nitrate. Dtsch Med Wochenschr 118:1532–1539

    Article  PubMed  CAS  Google Scholar 

  • ScherĂĽbl H, Hescheler J (1992) Patch-clamp-Technik und Ionenkanäle: Bedeutung in der Medizin. Dtsch Ă„rztebl 89:B-215-B–218

    Google Scholar 

  • Schlossmann J, Ammendola A, Ashman K, Zong X, Huber A, Neubauer G, Wang GX, Allescher HD, Korth M, Wilm M, Hofmann F, Ruth P (2000) Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase Ibeta. Nature 404:197–201

    Article  PubMed  CAS  Google Scholar 

  • Schmidt HHHW (1994) NO, endogener Botenstoff und Zellgift. Med Monatsschr Pharm 17:168–185

    PubMed  CAS  Google Scholar 

  • Schröder H (1992) Organische Nitrate: Neue Erkenntnisse zum Wirkungsmechanismus einer alten Substanzklasse. Med Monatsschr Pharm 15:134–139

    PubMed  Google Scholar 

  • Seasholtz TM, Majumdar M, Brown JH (1999) Rho as a mediator of G protein-coupled receptor signaling. Mol Pharmacol 55:949–956

    PubMed  CAS  Google Scholar 

  • Smyth EM, Keenan AK (1994) The vascular ANF-C receptor: Role in atrial peptide signalling. Cell Signal 6:125–133

    Article  PubMed  CAS  Google Scholar 

  • Somlyo AP, Somlyo AV (2000) Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 522.2:177–185

    Article  Google Scholar 

  • Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H (1998) Structural basis of drug binding to L Ca2+-channels. Trends Pharmacol Sci 19:108–115

    Article  PubMed  CAS  Google Scholar 

  • Sutko JL, Airey JA, Welch W, Ruest L (1997) The pharmacology of ryanodine and related compounds. Pharmacol Rev 49:53–98

    PubMed  CAS  Google Scholar 

  • Tang W-J, Gilman AG (1992) Adenylyl cyclases. Cell 70:869–872

    Article  PubMed  CAS  Google Scholar 

  • Thompson WJ (1991) Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function. Pharmacol Ther 51:13–33

    Article  PubMed  CAS  Google Scholar 

  • Zucchi R, Ronca-Testoni S (1997) The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: Modulation by endogenous effectors, drugs and disease states. Pharmacol Rev 49:1–51

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Oberdisse, E. (2002). Pharmaka mit Wirkung auf den glatten Muskel. In: Oberdisse, E., Hackenthal, E., Kuschinsky, K. (eds) Pharmakologie und Toxikologie. Springer-Lehrbuch. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56314-0_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56314-0_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62634-0

  • Online ISBN: 978-3-642-56314-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics